Trending Stocks: GlobeImmune Inc. (NASDAQ:GBIM), Chuy’s Holdings, Inc. (NASDAQ:CHUY), Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), Enerplus Corporation (NYSE:ERF), Gorman-Rupp Co. (NYSEMKT:GRC)

GlobeImmune Inc. (NASDAQ:GBIM) said that, it got some good news regarding one of its cancer drug candidates. GlobeImmune Inc. (NASDAQ:GBIM) belongs to Healthcare sector. Its weekly performance is 30.96%. On last trading day company shares ended up $2.94. GlobeImmune Inc. (NASDAQ:GBIM) distance from 50-day simple moving average (SMA50) is 0.99%.

On 4 August, Chuy’s Holdings, Inc. (NASDAQ:CHUY) announced financial results for the second quarter ended June 28, 2015. Net income increased 55.9% to $5.4 million, or $0.32 per diluted share, from $3.4 million, or $0.21 per diluted share. Chuy’s Holdings, Inc. (NASDAQ:CHUY) shares increased 22.96% in last trading session and ended the day at $34.22. CHUY Gross Margin is 72.20% and its return on assets is 6.90%. Chuy’s Holdings, Inc. (NASDAQ:CHUY) quarterly performance is 34.20%.

Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) reported financial results for the quarter ended June 30, 2015. For the second quarter of 2015, Tetraphase reported a net loss of $26.0 million, or $0.72 per share, compared to a net loss of $18.5 million, or $0.71 per share, for the same period in 2014.On 05 August, Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) shares fell -0.83% and was closed at $46.50. Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) year to date (YTD) performance is 17.10%.

Enerplus Corporation (NYSE:ERF) announced that a cash dividend in the amount of CDN$0.05 per share will be payable on August 14, 2015 to all shareholders of record at the close of business on July 30, 2015. The ex-dividend date for this payment is July 28, 2015.Enerplus Corporation (NYSE:ERF) ended the last trading day at $5.90. Company weekly volatility is calculated as 5.42% and price to cash ratio as 620.06. Enerplus Corporation (NYSE:ERF) showed a weekly performance of -10.06%.

Jefferies Group reaffirmed their hold rating on shares of Gorman-Rupp Co. (NYSEMKT:GRC) in a research note issued to investors on Monday. The firm currently has a $26.00 price target on the stock, down from their previous price target of $28.00.Gorman-Rupp Co. (NYSEMKT:GRC) shares fell -0.08% in last trading session and ended the day at $24.50. GRC Gross Margin is 24.20% and its return on assets is 8.10%. Gorman-Rupp Co. (NYSEMKT:GRC) quarterly performance is -10.35%.

Leave a Reply

Your email address will not be published. Required fields are marked *